Journal of Benefit-Cost Analysis

Papers
(The TQCC of Journal of Benefit-Cost Analysis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
A Benefit–Cost Analysis of Tulsa Pre-K, Based on Effects on High-School Graduation and College Attendance37
A Tale of the Tails: The Value of a Statistical Life at the Tails of the Age Distribution20
Funding a Just Transition Away from Coal in the U.S. Considering Avoided Damage from Air Pollution15
Cost–Benefit Analysis of Bus Fare Subsidies under Financial Constraints: The Case of Asunción, Paraguay15
Economic Evaluation Under Ambiguity and Structural Uncertainties14
Prospective Evaluation of Health Communication Effects on Market Outcomes14
From Benefit–Cost Analysis to Social Welfare: A Pragmatic Approach13
Mask Mandate Costs13
Be Brief, Be Consistent, Be Neutral: Comments on US Draft Circular A-4, “Regulatory Analysis”11
Why Office of Management and Budget’s (OMB) Social Welfare Function Is Not Society’s Social Welfare Function10
Benefit–cost analysis in the 5.9 GHz band9
BCA volume 13 issue 2 Cover and Back matter8
When Can Benefit–Cost Analyses Ignore Secondary Markets?8
Regulatory Impact Analysis and Litigation Risk8
Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach7
A Benefit-Cost Analysis of Increased International Migration of Skilled Labor in Africa and the World7
Demand for an Environmental Public Good in the Time of COVID-19: A Statewide Water Quality Referendum7
Categorizing and Ranking Graphs in Economics Research: The American Economic Review over the Last Century7
Social Welfare Functions and Health Policy: A New Approach6
Introduction to the Special Issue6
BCA volume 15 issue 3 Cover and Front matter6
Comparing the Draft and Final Circular A-46
The Incomparable Jerry Ellig5
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research5
Distribution and Disputation: Net Benefits, Equity, and Public Decision-Making5
The Broad Impacts of Disposable Lighter Safety Regulations5
Do Opportunity Costs of Regulations Appropriately Benefit or Inappropriately Burden Disadvantaged Consumers?5
Assessing Risk, Effectiveness, and Benefits in Transportation Regulation5
BCA volume 13 issue 1 Cover and Front matter5
The Global Burden of the COVID-19 Pandemic: Comparing Benefit–Cost Analysis and Social Welfare Analysis5
Benefit–Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit–Cost Ratio4
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic3
What OIRA Peer Reviewers Advised Regarding Notable Proposed Updates to Circular A-4: An Ignored Consensus?3
Is Communications-Company Ownership of Video Content a Threat to Competition?3
Advice on Guidance: Peer Review of Draft Circular A-4 “Regulatory Analysis”3
The Elasticity of Marginal Utility of Income for Distributional Weighting and Social Discounting: A Meta-Analysis3
Valuing a Reduction in the Risk and Severity of Asthma: A Large Scale Multi-Country Stated Preference Approach3
0.080853939056396